jRCT1040260037尚未招募不适用
Elucidation of the potential roles of PAPPis to enhance the effects of immune checkpoint inhibitors in endometrial cancer using patient-derived organoids
未提供0 个研究点目标入组 20 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20age old over 至 90age old under（—）
- 性别
- Female
入选标准
- •Patients diagnosed with endometrial cancer who undergo surgical treatment.
- •Patients aged 20 years or older and 90 years or younger at the time of consent.
- •Patients who have provided written informed consent to participate in the study.
排除标准
- •Patients deemed unsuitable for inclusion in the study at the discretion of the physician.
研究者
相似试验
招募中
不适用
A Post-marketing Clinical Study of Raguneprocel in Patients with Parkinson's DiseaseParkinson's diseasejRCT205326011735
招募中
不适用
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer*Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal AdenocarcinomajRCT2041260057840
已完成
1 期
A study to learn how PF-07817883 is taken up into the blood of healthy adults after taking tablets of study drug with varying ingredientscoronavirus disease 20192023-506442-24-00Pfizer Inc., Pfizer Inc.12
招募中
1 期
C5951001- A Phase 1 Study of PF-08046876 in Participants with Advanced Solid Tumors.advanced solid tumors2025-521729-33-00Pfizer Inc.70
已完成
1 期
A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PHASE I TRIAL TO INVESTIGATE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING TOPICAL DOSES OF GZ21T IN HEALTHY VOLUNTEERSActinic keratosis2024-512893-86-00Ankh Life Sciences Limited41